ATE127691T1 - Verwendung von vitamin-d-analoga zur behandlung von akne. - Google Patents

Verwendung von vitamin-d-analoga zur behandlung von akne.

Info

Publication number
ATE127691T1
ATE127691T1 AT91905594T AT91905594T ATE127691T1 AT E127691 T1 ATE127691 T1 AT E127691T1 AT 91905594 T AT91905594 T AT 91905594T AT 91905594 T AT91905594 T AT 91905594T AT E127691 T1 ATE127691 T1 AT E127691T1
Authority
AT
Austria
Prior art keywords
pct
vitamin
analogue
preparation
sec
Prior art date
Application number
AT91905594T
Other languages
English (en)
Inventor
Wagn Ole Godtfredsen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE127691T1 publication Critical patent/ATE127691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT91905594T 1990-03-01 1991-02-25 Verwendung von vitamin-d-analoga zur behandlung von akne. ATE127691T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004544A GB9004544D0 (en) 1990-03-01 1990-03-01 Novel treatment ii

Publications (1)

Publication Number Publication Date
ATE127691T1 true ATE127691T1 (de) 1995-09-15

Family

ID=10671792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905594T ATE127691T1 (de) 1990-03-01 1991-02-25 Verwendung von vitamin-d-analoga zur behandlung von akne.

Country Status (11)

Country Link
US (1) US5292727A (de)
EP (1) EP0517797B1 (de)
JP (1) JPH05504959A (de)
AT (1) ATE127691T1 (de)
AU (1) AU7458891A (de)
DE (1) DE69113029T2 (de)
DK (1) DK0517797T3 (de)
ES (1) ES2079063T3 (de)
GB (1) GB9004544D0 (de)
GR (1) GR3017413T3 (de)
WO (1) WO1991012807A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362719A (en) * 1990-03-01 1994-11-08 Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) Use of vitamin-D analogues in the treatment of acne
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
EP0835853A1 (de) * 1996-10-14 1998-04-15 Societe Europeenne De Propulsion Reibelement aus Kohlenstoff/Kohlenstoff-Siliciumcarbidverbundwerkstoff und Verfahren zu seiner Herstellung
US6432422B1 (en) * 1997-12-09 2002-08-13 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
AU743582B2 (en) * 1997-12-09 2002-01-31 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin D3 derivatives
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL199123B1 (pl) 1999-04-23 2008-08-29 Leo Pharm Prod Ltd Niewodna kompozycja farmaceutyczna do stosowania naskórnego i jej zastosowanie
AU6866900A (en) 1999-08-31 2001-03-26 Chugai Seiyaku Kabushiki Kaisha Soft capsules
RU2186269C2 (ru) * 2000-02-25 2002-07-27 Дальневосточная государственная морская академия им. адмирала Г.И. Невельского Способ получения антифрикционного покрытия на тонкостенных стальных вкладышах опор скольжения
CA2425367A1 (en) * 2000-08-30 2003-04-07 Chugai Seiyaku Kabushiki Kaisha Oct formulations
EP1458678A1 (de) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited Kristallisationsverfahren zur reinigung von calcipotriene
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
MX2007006261A (es) * 2004-11-22 2007-07-10 Wisconsin Alumni Res Found Analogos de 17,20(z)-deshidro vitamina d y sus usos.
WO2006129161A2 (en) 2005-06-01 2006-12-07 Stiefel Research Australia Pty Ltd Vitamin formulation
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
RU2452488C2 (ru) * 2006-08-29 2012-06-10 Тева Фармасьютикал Индастриес Лтд. Фармацевтические композиции, содержащие витамин группы d и кортикостероид
US20100273748A1 (en) * 2006-09-08 2010-10-28 The Regents Of The University Of California Antimicrobial therapy
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
PL2148661T3 (pl) 2007-04-25 2013-07-31 Cytochroma Inc Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
DK2148684T3 (da) 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
PT3335712T (pt) 2007-04-25 2025-10-23 Opko Renal Llc Método de tratamento e prevenção seguro e eficaz do hiperparatiroidismo secundário na doença renal crónica
US8592401B2 (en) 2007-04-25 2013-11-26 Proventiv Therapeutics, Llc Methods and compounds for vitamin D therapy
US7727562B2 (en) * 2007-06-21 2010-06-01 Blackman Steven T Liquid compositions containing solubilized benzoyl peroxide
CN102046812A (zh) 2008-04-02 2011-05-04 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
JP2014144929A (ja) * 2013-01-29 2014-08-14 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有するニキビの予防又は治療用組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
EP0215956A4 (de) * 1985-03-14 1988-09-07 Chugai Pharmaceutical Co Ltd Mittel zur behandlung von hautkrankheiten.
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
ATE99942T1 (de) * 1989-05-18 1994-01-15 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
AU7458891A (en) 1991-09-18
ES2079063T3 (es) 1996-01-01
JPH05504959A (ja) 1993-07-29
DE69113029T2 (de) 1996-03-07
WO1991012807A1 (en) 1991-09-05
GR3017413T3 (en) 1995-12-31
DE69113029D1 (de) 1995-10-19
EP0517797A1 (de) 1992-12-16
DK0517797T3 (da) 1995-11-13
EP0517797B1 (de) 1995-09-13
US5292727A (en) 1994-03-08
GB9004544D0 (en) 1990-04-25

Similar Documents

Publication Publication Date Title
ATE127691T1 (de) Verwendung von vitamin-d-analoga zur behandlung von akne.
BR9814984A (pt) Processos para tratar condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio em uma paciente pós-menopáusica e para reduzir o risco de fraturas ósseas osteoporóticas em uma paciente, e, conjunto para uso por uma comsumidora atormentada com, ou suscetìvel a, condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
ATE104854T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose.
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE114473T1 (de) Ausrüstung für die verwendung bei der behandlung von osteoporose.
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
NZ326345A (en) Composition containing diosgenin
DE69326122D1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ES2153689T3 (es) Pastilla de jabon antiseptico.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
BR9708511A (pt) Utilização de compostos utilização de ácido 6-[3-(1-adamantil)-4-metoxifenil]-2naftóico e utilização do ácido 6-[3-(1-adamantil)-4-hidroxifenil]-2-naftóico
ES2061293T3 (es) Procedimiento para el acondicionamiento y/o purificacion de isocianatos organicos.
NO955347L (no) Hormonelt middel for terapi av akne samt anvendelse derav
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin